Browsing Tag
London
132 posts
Virtual Science AI launches Medical Competitor AI as pharma launch teams demand sharper competitor intelligence
Pharma launch teams need sharper competitor intelligence. Virtual Science AI is turning medical activity tracking into an AI workflow.
Agentic AI has a data problem. Experian and ServiceNow think workflow decisioning is the fix
Agentic AI needs trusted data, not just automation. Experian and ServiceNow are turning decisioning into the next workflow battleground.
Image Analysis Group and HeartcoR Solutions target clinical trial bottlenecks with integrated core lab model
Clinical trials have too many data silos. IAG and HeartcoR Solutions are betting integrated core labs can cut friction for sponsors.
NICE Ltd (NASDAQ: NICE) jumps 10% into May 6 earnings as Cognigy AI thesis gains traction
NICE is down 28 percent over twelve months and trades at 10x earnings with a $955M agentic AI platform inside it. The May 6 print decides everything.
Pinnacle Investment Management (ASX: PNI) share price jumps 5% after Pacific Asset Management completion
Pinnacle just closed the $419m PAM deal and the stock bounced 5%. Affiliate FUM hits $202.5bn. Performance fees are the next test in July.
Golders Green stabbing: Counter Terrorism Policing formally declares terrorist attack on two Jewish men
Britain has poured millions into Jewish community security, yet a terrorist stabbed two Jewish men in Golders Green in broad daylight. The protection model is failing.
Hogan Lovells Cadwalader merger approved: Why the biggest law firm combination yet could reshape global finance law
Hogan Lovells Cadwalader has won partner approval for a July 1 launch. Read what the record law firm merger means for clients, rivals, and legal markets.
Berkeley Group (LON: BKG) halts land buying and cuts four-year profit outlook as geopolitical headwinds reshape London housebuilding strategy
Berkeley Group (BKG) freezes land buys, cuts four-year profit to £1.4bn amid geopolitical headwinds. What it means for London housing. Read the full analysis.
AccuQuant just raised $20m, but can AI-built financial infrastructure actually scale?
AccuQuant has raised $20 million to expand AI-driven financial infrastructure. Discover what this means for fintech automation and market competition.
GSK locks in ViiV Healthcare majority as Shionogi doubles down and Pfizer exits with $1.8bn
GSK retains 78.3% of ViiV Healthcare as Shionogi doubles its stake to 21.7% for $2.125 bn and Pfizer exits. Read the full strategic analysis.